Women With PCOS/PMOS At Higher Risk for Cardiovascular Disease

Introduction

Polycystic ovary syndrome/polyendocrine metabolic ovarian syndrome (PCOS/PMOS) is a prevalent endocrine disorder that affects women of reproductive age. It is characterized by the absence or infrequent ovulation (the process by which a female releases an egg/ovum in the menstrual cycle). However, PCOS/PMOS is not limited to reproductive health, as it can lead to metabolic syndrome, a condition that significantly increases the risk of cardiovascular disease. Recent clinical studies have shown that women with PCOS/PMOS have a higher cardiovascular risk profile due to alterations in their lipid/glucose metabolism, hypertension, systemic inflammation, and vascular injuries. These factors contribute to an increased risk of developing cardiovascular disease, which can severely impact a patient's quality of life.

What Is Polycystic Ovary Syndrome (PCOS/PMOS)?

• PCOS/PMOS is an endocrine disorder typically defined by the presence of at least two of three features, including irregular ovulation or the absence of ovulation, clinical or biochemical signs of excess androgen hormones, and the presence of polycystic ovaries.

• The exact causes of PCOS/PMOS are not entirely clear, but it appears to be related to a complex interplay between various factors such as the hypothalamic-pituitary-ovarian (HPO axis, which maintains the menstrual cycle) or hypothalamic-pituitary-adrenal axis (HPA axis, which produces stress response), metabolic disorders like obesity, insulin resistance, and compensatory hyperinsulinemia, and a genetic predisposition.

• Several theories attempt to explain the mechanisms behind the increased availability of androgen hormones, including excessive ovarian and adrenal production. Obesity is also associated with insulin resistance and compensatory hyperinsulinemia, which can further exacerbate the hormonal imbalances in PCOS/PMOS. The presence and activity of aromatase, a conversion enzyme found in fat cells, can also contribute to the altered release of androgens.

• Overall, the complexities of PCOS/PMOS require a multidisciplinary approach to diagnosis and management, including lifestyle interventions, pharmacological treatments, and potentially even surgical interventions in severe cases.

Do Women With PCOS/PMOS Have an Increased Risk for Cardiovascular Disease?

Research has revealed that women with PCOS/PMOS are more likely to have a number of cardiovascular disease (CVD) risk factors, including higher body mass index (BMI), blood pressure, levels of triglycerides, and LDL cholesterol. Moreover, they are more prone to experience metabolic syndrome, type 2 diabetes, and impaired glucose tolerance, all of which raise the risk of cardiovascular diseases.

What Are the Cardiovascular Risk Factors Observed in Women With PCOS/PMOS?

The risk factors for cardiovascular disease observed in women with PCOS/PMOS are explained below.

• Insulin Resistance and Type Two Diabetes: Insulin resistance, which occurs when the body is unable to use insulin to properly control blood sugar levels, is a defining characteristic of PCOS/PMOS. In order to make up for this, the pancreas generates extra insulin, which results in hyperinsulinemia (high insulin levels in the blood). This hyperinsulinemia can result in insulin resistance in several body regions, raising the risk of type 2 diabetes. Both insulin resistance and type 2 diabetes are independent risk factors for CVD.

• Obesity: Another risk factor for CVD is obesity, which is more prevalent in women with PCOS/PMOS. Hypertension, insulin resistance, and dyslipidemia (abnormal blood lipid levels) are all metabolic disorders linked to obesity (high blood pressure). The chance of having CVD is raised by these elements.

• Dyslipidemia: Women with PCOS/PMOS frequently have abnormal lipid levels, including raised LDL (low-density lipoprotein) cholesterol and triglyceride levels. An increased risk of atherosclerosis, or the formation of plaque in arteries, and future CVD is linked to these elevated lipid levels.

• Hypertension: Hypertension is a key risk factor for cardiovascular disease (CVD) and is more likely to occur in women with PCOS/PMOS. Blood vessels and organs, such as the heart, kidneys, and brain, can become damaged as a result of hypertension.

• Inflammation: C-reactive protein and other inflammatory markers are present in higher amounts in PCOS/PMOS women (CRP). Atherosclerosis formation and progression, as well as an increased risk of CVD, are linked to inflammation.

How Can the Risk of Cardiovascular Diseases Be Reduced in Women With PCOS/PMOS?

To lower this risk, there are a number of lifestyle modifications that can be made:

• Keeping the Weight in Check: Women with PCOS/PMOS are more likely to be overweight or obese, which raises the risk of developing cardiovascular disease. This risk can be decreased by maintaining a healthy weight with a balanced diet and regular exercise.

• Exercise Frequently: As insulin resistance is a prevalent symptom of PCOS/PMOS, exercise can help improve it. Cardiovascular health can be enhanced with regular exercises, such as brisk walking or cycling for at least 30 minutes each day.

• Stop Smoking: CVD is significantly increased by smoking. Smoking should be stopped by PCOS/PMOS women to lower their risk of cardiovascular disease (CVD).

• Controlling Stress: Long-term stress can cause cardiovascular disease (CVD). Deep breathing exercises, yoga, meditation, and other stress management methods can all help lower stress levels.

• Controlling Cholesterol and Blood Pressure: Women with PCOS/PMOS should routinely monitor their blood pressure and cholesterol levels because high levels of either can raise their risk of developing cardiovascular disease (CVD). In order to properly control these levels if they are high, individuals should cooperate with their healthcare physician.

What Are the Medications to Reduce Cardiovascular Disease Risk Factors in Women With PCOS/PMOS?

• Metformin: Insulin resistance in PCOS/PMOS is frequently treated with metformin. It has been shown to improve many cardiovascular risk factors, including blood pressure, lipid profile, and endothelial function.

• Oral Contraceptives: Women with PCOS/PMOS are frequently prescribed oral contraceptives to control menstrual periods and lower androgen levels. Moreover, they can enhance lipid profiles and lower the risk of endometrial cancer.

• Statins: Statins are taken to lower cholesterol and lower the risk of cardiovascular disease. These are frequently given as prescriptions to PCOS/PMOS patients who have elevated cholesterol.

• Anti-hypertensive Medications: Women with PCOS/PMOS may have higher blood pressure levels, which raises their risk of CVD. Anti-hypertensive drugs, such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), can help lower blood pressure levels.

Conclusion

In conclusion, PCOSPMOS is not just a reproductive disorder, but it is also a cardiovascular risk factor that significantly affects a patient's health integrity. The complex systemic symptoms of PCOS/PMOS, including metabolic syndrome, hypertension, and systemic inflammation, can lead to severe cardiovascular disease. Early detection and management of PCOS/PMOS are crucial in preventing the onset of cardiovascular disease. Lifestyle changes, such as exercise and diet modifications, are effective in managing the symptoms of PCOS/PMOS and reducing the risk of developing cardiovascular disease. Additionally, early intervention with medications such as Metformin, oral contraceptives, and anti-androgens can help manage the symptoms of PCOS/PMOS and prevent the onset of cardiovascular disease.